Human IL-6RhiTIGIT− CD4+ CD127lowCD25+ T cells display potent in vitro suppressive capacity and a distinct Th17 profile

[1]  J. Todd,et al.  In-depth immunophenotyping data of IL-6R on the human peripheral regulatory T cell (Treg) compartment , 2017, Data in brief.

[2]  S. Heink.  Multiple Sklerose: Neu entdeckter Signalmechanismus macht T-Zellen pathogen , 2017 .

[3]  Adrian P Mander,et al.  Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial , 2016, PLoS medicine.

[4]  K. Cerosaletti,et al.  Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression , 2016, Science Translational Medicine.

[5]  Sara Omenetti,et al.  The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome , 2015, Front. Immunol..

[6]  J. Todd,et al.  Epigenetic analysis of regulatory T cells using multiplex bisulfite sequencing , 2015, European journal of immunology.

[7]  S. Heck,et al.  Phenotypic Complexity of the Human Regulatory T Cell Compartment Revealed by Mass Cytometry , 2015, The Journal of Immunology.

[8]  F. Powrie,et al.  Microbiota RORgulates intestinal suppressor T cells , 2015, Science.

[9]  D. Voehringer,et al.  The microbiota regulates type 2 immunity through RORγt+ T cells , 2015, Science.

[10]  Liza Konnikova,et al.  Individual intestinal symbionts induce a distinct population of RORγ+ regulatory T cells , 2015, Science.

[11]  M. Beckstette,et al.  Foxp3+ T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation , 2015, Mucosal Immunology.

[12]  H. Baker,et al.  Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226 , 2015, The Journal of Immunology.

[13]  Judy H. Cho,et al.  Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies , 2015, Nature Medicine.

[14]  R. Balderas,et al.  Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3high regulatory T cells in humans , 2015, Proceedings of the National Academy of Sciences.

[15]  E. d'Hennezel,et al.  Coexpression of TIGIT and FCRL3 Identifies Helios+ Human Memory Regulatory T Cells , 2015, The Journal of Immunology.

[16]  H. Weiner,et al.  Nonapoptotic and Extracellular Activity of Granzyme B Mediates Resistance to Regulatory T Cell (Treg) Suppression by HLA-DR−CD25hiCD127lo Tregs in Multiple Sclerosis and in Response to IL-6 , 2015, The Journal of Immunology.

[17]  S. Sakaguchi,et al.  Epigenetic control of thymic Treg‐cell development , 2015, European journal of immunology.

[18]  D. Bending,et al.  Hypomethylation at the Regulatory T Cell–Specific Demethylated Region in CD25hi T Cells Is Decoupled from FOXP3 Expression at the Inflamed Site in Childhood Arthritis , 2014, The Journal of Immunology.

[19]  J. Todd,et al.  Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial , 2014, BMJ Open.

[20]  Farrah C. Steinke,et al.  From inception to output, Tcf1 and Lef1 safeguard development of T cells and innate immune cells , 2014, Immunologic Research.

[21]  Yan Gao,et al.  T cell-intrinsic role of IL-6 signaling in primary and memory responses , 2014, eLife.

[22]  S. Hori.  Lineage stability and phenotypic plasticity of Foxp3+ regulatory T cells , 2014, Immunological reviews.

[23]  Deepali V. Sawant,et al.  Once a Treg, always a Treg? , 2014, Immunological reviews.

[24]  C. Benoist,et al.  Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. , 2014, Immunity.

[25]  Daniel Nilsson,et al.  An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge , 2014, Genome Biology.

[26]  Ningli Li,et al.  Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood , 2014, Annals of the rheumatic diseases.

[27]  Elizabeth Whalen,et al.  Multiple Autoimmune-Associated Variants Confer Decreased IL-2R Signaling in CD4+CD25hi T Cells of Type 1 Diabetic and Multiple Sclerosis Patients , 2013, PloS one.

[28]  Hiroshi Takayanagi,et al.  Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis , 2013, Nature Medicine.

[29]  D. Valmori,et al.  Human Memory Helios− FOXP3+ Regulatory T Cells (Tregs) Encompass Induced Tregs That Express Aiolos and Respond to IL-1β by Downregulating Their Suppressor Functions , 2013, The Journal of Immunology.

[30]  J. Karbach,et al.  Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans , 2013, Proceedings of the National Academy of Sciences.

[31]  Peter Donnelly,et al.  Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci , 2013, Nature Genetics.

[32]  Clelia Di Serio,et al.  Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells , 2013, Nature Medicine.

[33]  S. Sakaguchi,et al.  Molecular Determinants of Regulatory T Cell Development: The Essential Roles of Epigenetic Changes , 2013, Front. Immunol..

[34]  V. Lefebvre,et al.  A network of high-mobility group box transcription factors programs innate interleukin-17 production. , 2013, Immunity.

[35]  D. Bending,et al.  CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines. , 2013, Blood.

[36]  Daniel F. Freitag,et al.  Functional IL6R 358Ala Allele Impairs Classical IL-6 Receptor Signaling and Influences Risk of Diverse Inflammatory Diseases , 2013, PLoS genetics.

[37]  R. Sellers,et al.  Helios Induces Epigenetic Silencing of Il2 Gene Expression in Regulatory T Cells , 2013, The Journal of Immunology.

[38]  Eli Stahl,et al.  High density genetic mapping identifies new susceptibility loci for rheumatoid arthritis , 2012, Nature Genetics.

[39]  J. Seavitt,et al.  Aiolos promotes TH17 differentiation by directly silencing Il2 expression , 2012, Nature Immunology.

[40]  Antonio Lanzavecchia,et al.  Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. , 2012, Blood.

[41]  Linda S. Wicker,et al.  Type 1 Diabetes-Associated IL2RA Variation Lowers IL-2 Signaling and Contributes to Diminished CD4+CD25+ Regulatory T Cell Function , 2012, The Journal of Immunology.

[42]  J. Ritz,et al.  Interleukin-2 and regulatory T cells in graft-versus-host disease. , 2011, The New England journal of medicine.

[43]  F. Carrat,et al.  Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. , 2011, The New England journal of medicine.

[44]  J. Scheller,et al.  Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. , 2011, The Journal of clinical investigation.

[45]  Jonathan H. Esensten,et al.  Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes , 2011, The Journal of Immunology.

[46]  D. Littman,et al.  Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. , 2011, Gastroenterology.

[47]  Tariq Ahmad,et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.

[48]  Jing Cui,et al.  Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci , 2010, Nature Genetics.

[49]  Xiaoxiao Wan,et al.  FoxP3+RORγt+ T Helper Intermediates Display Suppressive Function against Autoimmune Diabetes , 2010, The Journal of Immunology.

[50]  C. Benoist,et al.  Genomic definition of multiple ex vivo regulatory T cell subphenotypes , 2010, Proceedings of the National Academy of Sciences.

[51]  R. D. Hatton,et al.  Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective , 2009, Nature Reviews Immunology.

[52]  A. Levine,et al.  IL-6 Signaling in Psoriasis Prevents Immune Suppression by Regulatory T Cells1 , 2009, The Journal of Immunology.

[53]  J. Bluestone,et al.  Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo , 2009, Nature Immunology.

[54]  E. Shevach.  Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.

[55]  C. Baecher-Allan,et al.  IL-17-producing human peripheral regulatory T cells retain suppressive function. , 2009, Blood.

[56]  R. Nurieva,et al.  Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. , 2009, Immunity.

[57]  Danila Valmori,et al.  Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORγt , 2009, Proceedings of the National Academy of Sciences.

[58]  D. Littman,et al.  Identification of IL-17-producing FOXP3+ regulatory T cells in humans , 2009, Proceedings of the National Academy of Sciences.

[59]  B. Malissen,et al.  Heterogeneity of natural Foxp3+ T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity , 2009, Proceedings of the National Academy of Sciences.

[60]  Alf Hamann,et al.  Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? , 2009, Nature Reviews Immunology.

[61]  T. Nomura,et al.  CTLA-4 Control over Foxp3+ Regulatory T Cell Function , 2008, Science.

[62]  Irma Joosten,et al.  Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. , 2008, Blood.

[63]  L. Cosmi,et al.  Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursor , 2008, The Journal of experimental medicine.

[64]  Chen Dong,et al.  Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. , 2008, Immunity.

[65]  David E. Anderson,et al.  IL-21 and TGF-β are required for differentiation of human TH17 cells , 2008, Nature.

[66]  D. Riethmacher,et al.  In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells , 2008, The Journal of experimental medicine.

[67]  M. Rincón,et al.  Cutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells1 , 2008, The Journal of Immunology.

[68]  J. Bluestone,et al.  Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. , 2008, Immunity.

[69]  Yuelei Shen,et al.  TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function , 2008, Nature.

[70]  Mark Atkinson,et al.  Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes , 2007, Nature Genetics.

[71]  S. Gabriel,et al.  Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.

[72]  D. Jarrossay,et al.  Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.

[73]  W. Strober,et al.  Cutting Edge: Regulatory T Cells Induce CD4+CD25−Foxp3− T Cells or Are Self-Induced to Become Th17 Cells in the Absence of Exogenous TGF-β , 2007, The Journal of Immunology.

[74]  J. Rogers,et al.  Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity , 2007, Nature Genetics.

[75]  Katharina Fleischhauer,et al.  Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans , 2006, Immunological reviews.

[76]  L. Walker,et al.  The role of CD28 and cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) in regulatory T‐cell biology , 2006, Immunological reviews.

[77]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[78]  S. Rose-John,et al.  Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25high regulatory T cells. , 2006, International immunology.

[79]  R. J. Hocking,et al.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.

[80]  Ruslan Medzhitov,et al.  Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells , 2003, Science.

[81]  H. Blum,et al.  Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH 17 cells , 2022 .